{
    "medicine_id": "b93fe77c00d91cce577df6b5ae5cf814a77072a0",
    "platform_id": "DB04849",
    "metadata": {
        "name": "Ixempra 15 mg 15mg Kit",
        "composition": "15 mg 15mg Cediranib",
        "clinical_particulars": {
            "therapeutic_indications": "For the treatment of liver cancer advanced non small cell lung cancer NSCLC advanced colorectal cancer CRC and other solid tumors",
            "contraindications": {
                "disease": "NA",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "Cediranib is a once daily orally available highly potent and selective VEGF signalling inhibitor that inhibits all three VEGF receptors The preclinical profile of Cediranib indicates that it has the potential to be the best in class VEGF signalling inhibitor Phase I data indicate that Cediranib is generally well tolerated with the most common dose related adverse events being diarrhoea hoarseness headache and hypertension",
                "excipients": "NA",
                "incompatibilities": [
                    {
                        "drugbank-id": "DB00012",
                        "description": "The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Cediranib"
                    },
                    {
                        "drugbank-id": "DB00016",
                        "description": "The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Cediranib"
                    },
                    {
                        "drugbank-id": "DB08894",
                        "description": "The risk or severity of Thrombosis can be increased when Peginesatide is combined with Cediranib"
                    },
                    {
                        "drugbank-id": "DB09107",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Cediranib"
                    },
                    {
                        "drugbank-id": "DB00316",
                        "description": "The serum concentration of Acetaminophen can be increased when it is combined with Cediranib"
                    },
                    {
                        "drugbank-id": "DB09288",
                        "description": "The serum concentration of Propacetamol can be increased when it is combined with Cediranib"
                    },
                    {
                        "drugbank-id": "DB00017",
                        "description": "The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Cediranib"
                    },
                    {
                        "drugbank-id": "DB00024",
                        "description": "The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Cediranib"
                    },
                    {
                        "drugbank-id": "DB00066",
                        "description": "The therapeutic efficacy of Follitropin can be decreased when used in combination with Cediranib"
                    },
                    {
                        "drugbank-id": "DB00279",
                        "description": "The therapeutic efficacy of Liothyronine can be decreased when used in combination with Cediranib"
                    },
                    {
                        "drugbank-id": "DB00389",
                        "description": "The therapeutic efficacy of Carbimazole can be decreased when used in combination with Cediranib"
                    },
                    {
                        "drugbank-id": "DB00451",
                        "description": "The therapeutic efficacy of Levothyroxine can be decreased when used in combination with Cediranib"
                    },
                    {
                        "drugbank-id": "DB00550",
                        "description": "The therapeutic efficacy of Propylthiouracil can be decreased when used in combination with Cediranib"
                    },
                    {
                        "drugbank-id": "DB00763",
                        "description": "The therapeutic efficacy of Methimazole can be decreased when used in combination with Cediranib"
                    },
                    {
                        "drugbank-id": "DB01583",
                        "description": "The therapeutic efficacy of Liotrix can be decreased when used in combination with Cediranib"
                    },
                    {
                        "drugbank-id": "DB03374",
                        "description": "The therapeutic efficacy of 3 5 Diiodotyrosine can be decreased when used in combination with Cediranib"
                    },
                    {
                        "drugbank-id": "DB03604",
                        "description": "The therapeutic efficacy of Tiratricol can be decreased when used in combination with Cediranib"
                    },
                    {
                        "drugbank-id": "DB05084",
                        "description": "The therapeutic efficacy of Abaloparatide can be decreased when used in combination with Cediranib"
                    },
                    {
                        "drugbank-id": "DB05829",
                        "description": "The therapeutic efficacy of Parathyroid hormone can be decreased when used in combination with Cediranib"
                    },
                    {
                        "drugbank-id": "DB06285",
                        "description": "The therapeutic efficacy of Teriparatide can be decreased when used in combination with Cediranib"
                    },
                    {
                        "drugbank-id": "DB06715",
                        "description": "The therapeutic efficacy of Potassium Iodide can be decreased when used in combination with Cediranib"
                    },
                    {
                        "drugbank-id": "DB07637",
                        "description": "The therapeutic efficacy of Dibromotyrosine can be decreased when used in combination with Cediranib"
                    },
                    {
                        "drugbank-id": "DB09100",
                        "description": "The therapeutic efficacy of Thyroid porcine can be decreased when used in combination with Cediranib"
                    },
                    {
                        "drugbank-id": "DB09418",
                        "description": "The therapeutic efficacy of Potassium perchlorate can be decreased when used in combination with Cediranib"
                    },
                    {
                        "drugbank-id": "DB09421",
                        "description": "The therapeutic efficacy of Protirelin can be decreased when used in combination with Cediranib"
                    },
                    {
                        "drugbank-id": "DB12629",
                        "description": "The therapeutic efficacy of 3 5 diiodothyropropionic acid can be decreased when used in combination with Cediranib"
                    },
                    {
                        "drugbank-id": "DB13644",
                        "description": "The therapeutic efficacy of Methylthiouracil can be decreased when used in combination with Cediranib"
                    },
                    {
                        "drugbank-id": "DB13742",
                        "description": "The therapeutic efficacy of Elcatonin can be decreased when used in combination with Cediranib"
                    },
                    {
                        "drugbank-id": "DB13804",
                        "description": "The therapeutic efficacy of Benzylthiouracil can be decreased when used in combination with Cediranib"
                    },
                    {
                        "drugbank-id": "DB15263",
                        "description": "The therapeutic efficacy of Thyrotropin can be decreased when used in combination with Cediranib"
                    }
                ]
            }
        },
        "revision_date": "2023-05-14"
    }
}